Orna Buys Competing RNA Biotech ReNAgade After Series A Financing

Published: May 23, 2024 By Tyler Patchen


Pictured: Two business professionals in suits shaking hands/iStock, fizkes

Massachusetts-based Orna Therapeutics announced on Thursday it is acquiring competing RNA biotech ReNAgade Therapeutics. The terms of the acquisition were not disclosed. 

ReNAgade launched in…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

Advertise With Biotech Networks